Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2020-11-30

FDA Approved: ZYRTEC — Supplemental Application (Kenvue Brands LLC)

View source ↗

Summary

FDA approved a supplemental application for ZYRTEC (cetirizine hydrochloride) to update the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZYRTEC (cetirizine hydrochloride)

Snippet

SUPPL AP for ZYRTEC (CETIRIZINE HYDROCHLORIDE)